0001209191-17-052021.txt : 20170908 0001209191-17-052021.hdr.sgml : 20170908 20170908145847 ACCESSION NUMBER: 0001209191-17-052021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170906 FILED AS OF DATE: 20170908 DATE AS OF CHANGE: 20170908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gano Kyle CENTRAL INDEX KEY: 0001567160 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22705 FILM NUMBER: 171076315 MAIL ADDRESS: STREET 1: NEUROCRINE BIOSCIENCES, INC. STREET 2: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC CENTRAL INDEX KEY: 0000914475 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330525145 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 617-7600 MAIL ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-09-06 0 0000914475 NEUROCRINE BIOSCIENCES INC NBIX 0001567160 Gano Kyle 12780 EL CAMINO REAL SAN DIEGO CA 92130 0 1 0 0 Chief Business Development Off Common Stock 2017-09-06 4 M 0 4607 8.65 A 77853 D Common Stock 2017-09-06 4 S 0 4607 60.00 D 73246 D Stock Option 8.65 2017-09-06 4 M 0 4607 8.65 D 2023-01-10 Common Stock 4607 55390 D The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Option granted January 10, 2013 and vested monthly over four years. /s/Darin Lippoldt, Attorney-In-Fact 2017-09-08